Morgan Bree Messer, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Twelve Oaks Center Dr Ste 662, Wayzata, MN 55391 Phone: 612-999-8526 |
Rebecca Chesin, MA, LAMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Twelve Oaks Center Dr, Wayzata, MN 55391 Phone: 763-458-6896 |
Katherine Jane Haskin, L.M.F.T. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Twelve Oaks Center Dr, Suite 642e, Wayzata, MN 55391 Phone: 612-807-0878 |
Dorit Atar, MS, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Twelve Oaks Center Dr, Wayzata, MN 55391 Phone: 952-564-0588 |
News Archive
Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death.
How do cells in our immune system recognise dangerous invaders and hazardous cells, such as cancer cells? Answers to this and similar questions are evolving rapidly. A large contributor worldwide to the field of immunology is the NCMLS, Nijmegen Centre for Molecular Life Sciences of the Radboud University Nijmegen Medical Centre. The NCMLS is organising an important scientific congress on this very topic, for which the absolute world top immunology experts are coming to Nijmegen.
During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.
BioMarin Pharmaceutical Inc. announced today that it has acquired Huxley Pharmaceuticals, Inc. (Huxley), which has rights to a proprietary form of 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd., based in Seoul, South Korea for the distribution of ProbiĀ“s gut health product, Probi MageĀ®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014.
› Verified 1 days ago